TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 78 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,652 | -70.3% | 309 | -70.1% | 0.00% | -100.0% |
| Q2 2023 | $39,258 | – | 1,035 | +5988.2% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 17 | -84.1% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 107 | -23.6% | 0.00% | – |
| Q2 2022 | $5,000 | – | 140 | +3400.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 4 | -88.6% | 0.00% | – |
| Q4 2021 | $2,000 | – | 35 | +600.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 5 | -99.8% | 0.00% | -100.0% |
| Q2 2021 | $174,000 | +35.9% | 2,424 | +39.4% | 0.01% | +150.0% |
| Q1 2021 | $128,000 | +456.5% | 1,739 | +457.4% | 0.00% | +100.0% |
| Q4 2020 | $23,000 | +9.5% | 312 | -19.8% | 0.00% | – |
| Q3 2020 | $21,000 | +61.5% | 389 | +100.5% | 0.00% | -100.0% |
| Q2 2020 | $13,000 | -13.3% | 194 | -19.2% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | -91.4% | 240 | -87.9% | 0.00% | -92.9% |
| Q4 2019 | $174,000 | +2385.7% | 1,980 | +1941.2% | 0.01% | – |
| Q3 2019 | $7,000 | -97.8% | 97 | -97.5% | 0.00% | -100.0% |
| Q2 2019 | $325,000 | +371.0% | 3,810 | +500.9% | 0.02% | +450.0% |
| Q1 2019 | $69,000 | -90.0% | 634 | -92.2% | 0.00% | -92.0% |
| Q4 2018 | $687,000 | +370.5% | 8,118 | +447.0% | 0.05% | +354.5% |
| Q3 2018 | $146,000 | -29.8% | 1,484 | -17.6% | 0.01% | -8.3% |
| Q2 2018 | $208,000 | -62.0% | 1,802 | -67.5% | 0.01% | -74.5% |
| Q1 2018 | $548,000 | +74.5% | 5,549 | +85.3% | 0.05% | +14.6% |
| Q4 2017 | $314,000 | +157.4% | 2,995 | +176.8% | 0.04% | +310.0% |
| Q3 2017 | $122,000 | -52.9% | 1,082 | -51.3% | 0.01% | -61.5% |
| Q1 2017 | $259,000 | +12850.0% | 2,224 | +11020.0% | 0.03% | – |
| Q4 2016 | $2,000 | -88.9% | 20 | -87.7% | 0.00% | -100.0% |
| Q3 2016 | $18,000 | -56.1% | 162 | -42.6% | 0.00% | -50.0% |
| Q2 2016 | $41,000 | +95.2% | 282 | +94.5% | 0.00% | +33.3% |
| Q1 2016 | $21,000 | +320.0% | 145 | +314.3% | 0.00% | – |
| Q3 2015 | $5,000 | +150.0% | 35 | +191.7% | 0.00% | – |
| Q2 2015 | $2,000 | -96.5% | 12 | -97.9% | 0.00% | -100.0% |
| Q4 2013 | $57,000 | +612.5% | 576 | +476.0% | 0.01% | +900.0% |
| Q3 2013 | $8,000 | -61.9% | 100 | -73.8% | 0.00% | -50.0% |
| Q2 2013 | $21,000 | – | 382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |